Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol.84, no.3, pp.568-578, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 84 Issue: 3
- Publication Date: 2018
- Doi Number: 10.1111/bcp.13481
- Journal Name: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.568-578
- Keywords: diabetes, metformin, observational study, pregnancy, spontaneous abortion, teratogen, SPONTANEOUS-ABORTION, BIRTH-DEFECTS, 1ST-TRIMESTER EXPOSURE, OBSERVATIONAL COHORT, INSULIN, RISK, MULTICENTER, OBESITY, AGENTS
- Karadeniz Technical University Affiliated: Yes
Abstract
AimsMetformin is used to treat type 2 diabetes, polycystic ovary syndrome associated infertility, and gestational diabetes. This study aims to evaluate the safety of metformin in early pregnancy.